Scarlet
Well-known member
This still needs to go through human trials but it looks promising. Hopefully it'll get proper funding but I wouldn't count on it.
https://www.nature.com/articles/s41564-023-01352-8
https://www.nature.com/articles/s41564-023-01352-8
Our results show that sCPD9 vaccination elicited the most robust immunity, including rapid viral clearance, reduced tissue damage, fast differentiation of pre-plasmablasts, strong systemic and mucosal humoral responses, and rapid recall of memory T cells from lung tissue after challenge with heterologous SARS-CoV-2. Overall, our results demonstrate that live-attenuated vaccines offer advantages over currently available COVID-19 vaccines.